Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective

被引:608
作者
Ratnam, D. Venkat [1 ]
Ankola, D. D. [1 ]
Bhardwaj, V. [1 ]
Sahana, D. K. [1 ]
Kumar, M. N. V. Ravi [1 ]
机构
[1] NIPER, Dept Pharmaceut, Mohali 160062, Punjab, India
关键词
antioxidants; biopharmaceutics; controlled delivery; intestinal permeability; peroral; pharmacokinetics; solubility; targeted delivery;
D O I
10.1016/j.jconrel.2006.04.015
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Antioxidants are emerging as prophylactic and therapeutic agents. These are the agents, which scavenge free radicals otherwise reactive oxygen species and prevent the damage caused by them. Free radicals have been associated with pathogenesis of various disorders like cancer, diabetes, cardiovascular diseases, autoimmune diseases, neurodegenerative disorders and are implicated in aging. Several antioxidants like SOD, CAT, epigallocatechin-3-O-gallate, lycopene, ellagic acid, coenzyme Q(10), indole-3-carbinol, genistein, quercetin, vitamin C and vitamin E have been found to be pharmacologically active as prophylactic and therapeutic agents for above mentioned diseases. Antioxidants are part of diet but their bioavailability through dietary supplementation depends on several factors. This major drawback of dietary agents may be due to one or many of the several factors like poor solubility, inefficient permeability, instability due to storage of food, first pass effect and GI degradation. Conventional dosage forms may not result in efficient formulation owing to their poor biopharmaceutical properties. Principles of novel drug delivery systems need to be applied to significantly improve the performance of antioxidants. Novel drug delivery systems (NDDS) would also help in delivery of these antioxidants by oral route, as this route is of prime importance when antioxidants are intended for prophylactic purpose. Implication of NDDS for the delivery of antioxidants is largely governed by physicochemical characteristics, biopharmaceutical properties and pharmacokinetic parameters of the antioxidant to be formulated. Recently, chemical modifications, coupling agents, liposomes, microparticles, nanoparticles and gel-based systems have been explored for the delivery of these difficult to deliver molecules. Results from several studies conducted across the globe are positive and provided us with new anticipation for the improvement of human healthcare. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:189 / 207
页数:19
相关论文
共 149 条
[1]  
ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3582
[2]   Nanomedicines for overcoming biological barriers [J].
Alonso, MJ .
BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (03) :168-172
[3]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[4]   Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice [J].
Anderton, MJ ;
Manson, MM ;
Verschoyle, RD ;
Gescher, A ;
Lamb, JH ;
Farmer, PB ;
Steward, WP ;
Williams, ML .
CLINICAL CANCER RESEARCH, 2004, 10 (15) :5233-5241
[5]  
Andya JD, 2003, AAPS PHARMSCI, V5
[6]  
ANUPONGSANUGOOL E, 2005, CLIN PHARM, V5, P2
[7]   The coenzyme Q10 analog decylubiquinone inhibits the redox-activated mitochondrial permeability transition - Role of mitochondrial respiratory complex III [J].
Armstrong, JS ;
Whiteman, M ;
Rose, P ;
Jones, DP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (49) :49079-49084
[8]   The type of sugar moiety is a major determinant of the small intestinal uptake and subsequent biliary excretion of dietary quercetin glycosides [J].
Arts, ICW ;
Sesink, ALA ;
Faassen-Peters, M ;
Hollman, PCH .
BRITISH JOURNAL OF NUTRITION, 2004, 91 (06) :841-847
[9]   Free radical biology - terminology and critical thinking [J].
Azzi, A ;
Davies, KJA ;
Kelly, F .
FEBS LETTERS, 2004, 558 (1-3) :3-6
[10]   Sustained release nanoparticulate formulation containing antioxidant-ellagic acid as potential prophylaxis system for oral administration [J].
Bala, I ;
Bhardwaj, V ;
Hariharan, S ;
Kharade, SV ;
Roy, N ;
Kumar, MNVR .
JOURNAL OF DRUG TARGETING, 2006, 14 (01) :27-34